Award
National Heart, Lung, and Blood Institute 5U24HL153846-05
Randomized Evaluation of Bromocriptine In Myocardial Recovery Therapy for Peripartum Cardiomyopathy (REBIRTH)
Recipient
University of Pittsburgh
Award Amount
$384,826.00
Ceiling
$384,826.00
Awarded
August 15, 2025
Identifier
5U24HL153846-05
NIH grant awarded to University of Pittsburgh for a clinical trial on bromocriptine therapy in peripartum cardiomyopathy with a budget of $384,826 from 2021 to 2026.
Description
This is a NIH grant project for a clinical trial evaluating bromocriptine therapy for peripartum cardiomyopathy. The project involves data coordination, protocol development, and statistical analysis.